In accordance with Regulation 30 of SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015 ("Listing Regulations"), we hereby enclose thefollowing documents:1. Copy of Intimation sent to those shareholders whose Dividend has remainedunclaimed since FY 2017-18 for a period of seven consecutive years or morerequesting them to claim the dividend from the Company by contacting its Registrarand Share Transfer Agent, MUFG lntime India Private Limited, by Monday, August25, 2025.2. Copy of Notice published on May 29, 2025 in Business Standard (English) andMumbai Lakshwadeep (Marathi).The list of shareholders whose shares are liable to be transferred to IEPF Authority hasbeen uploaded on the website of the Company at: www.rpglifesciences.com under the"Investor Tab".
RPGLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
RPG Life Sciences has issued a notice to shareholders whose dividends have remained unclaimed for seven consecutive years (from FY 2017-18 onwards) warning that their equity shares will be transferred to the Investor Education and Protection Fund (IEPF) Account. Shareholders have until Monday, August 25, 2025, to claim their unpaid dividends (covering 7 financial years from 2017-18 to 2023-24) by submitting the required claim forms to the Registrar, MUFG Intime India Private Limited. Public notices were published in Business Standard (English) and Mumbai Lakshwadeep (Marathi) on May 29, 2025, and the list of affected shareholders has been uploaded to the company's website. This action is being taken in line with Section 124(6) of the Companies Act, 2013 and the IEPF Rules, 2016.
This is a routine regulatory compliance action and is unlikely to impact the stock price or company operations. Only a small set of shareholders who have not claimed dividends since FY 2017-18 are affected, and they retain the right to claim their shares back from the IEPF Authority by filing Form IEPF-5 even after the transfer.